Document is current

Article History

Received: 1 December 2024

Accepted: 24 April 2025

First Online: 15 May 2025

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee Hospital Universitari Mútua Terrassa (P/22–074) on September 22nd, 2022, with the need for written informed consent waived.

: Informed consent for information published in this article was not obtained due to the impossibility of obtaining consent from the subjects without disproportionate effort and the use of data in terms that do not allow the direct or indirect identification of participants. The waiver of informed consent was granted in accordance with Article 58 of the Biomedical Research Law 14/2007, and was evaluated and favorably approved by the relevant ethics committee.

: Not applicable.

: C.L. has served as a speaker for Boston Scientific and consulting fees from Fujifilm. M.E. reports grants and personal fees from AbbVie and Jansen as well as travel grants for educational and scientific meetings from AbbVie, Takeda and Ferring, outside the submitted work. Y.Z. has received support for conference attendance, speaker fees, research support and consulting fees from AbbVie, Adacyte, Dr Falk Pharma, FAES Pharma, Ferring, Janssen, Pfizer, Takeda, Galapagos, Boehringer Ingelheim and Tillots.